The lack of restoration in renal ACE2 in olmesartan-treated adenine mice might have been due to the use of a different CKD model, compared with a previous study27, as well as the relatively short duration of angiotensin receptor blocker treatment25,27. This evidence concerns the gene ACE2 and chronic kidney disease.